TEM vs CVS
diagnostics · CVS Health
| TEM diagnostics Healthcare | CVS CVS Health Healthcare | |
|---|---|---|
| Market | ||
| Price | $81.56 +3.92% | $88.91 +0.45% |
| Market cap | $13.2B | $115.4B |
| P/E (TTM) | — | 23.6 |
| Dividend yield | — | 3.49% |
| 52-week range | $40.77 – $91.83 | $69.51 – $110.68 |
| Our research | ||
| Our view | LONG open | LONG open |
| Articles | 1 | 1 |
| Latest article | Tempus Grew Revenue 23%, But A $42.8 Million Securities Gain Helped The Loss Nov 3, 2026 | CVS Health's Aetna MBR Just Hit 84.6% — Five Straight Beats Say The Turnaround Is Real (C… Jun 30, 2026 |
| Latest earnings | ||
| Reported | — | Aug 5, 2026 |
| Revenue | — | $106.1 billion +7.3% YoY |
| EPS | — | $2.31 |
| Guidance | — | Guidance raised |
| Revenue growth, last 4 reports | — | +7.3% |
| Topics | ||
| Main topics | ||
| Company page | Company page · Earnings releases | |
Note. Earnings figures are extracted automatically from each company's own release; prices are delayed up to 15 minutes. This comparison is information, not investment advice.